“…The role of lymphangiogenesis has been investigated in different chronic hepatobiliary diseases, as well as in ischemia–reperfusion injury [ 15 , 16 , 23 , 24 , 25 , 26 , 27 ]. In fact, the activation of lymphangiogenesis has been found in chronic viral hepatitis, non-alcoholic fatty liver disease, alcohol-associated liver disease, primary biliary cholangitis, and primary sclerosing cholangitis, resulting in an increased number of lymphatic vessels near areas of fibrosis in conjunction with an inflammatory infiltrate [ 15 , 16 , 23 , 24 , 25 , 26 ]. Moreover, in non-alcoholic steatohepatitis, increased levels of oxidized low-density lipoproteins promote inflammatory signals and reduce Prox1 levels, leading to decreased lymphatic stability and alterations in liver homeostasis [ 23 ].…”